{"id":24070,"date":"2026-08-10T08:13:20","date_gmt":"2026-08-10T08:13:20","guid":{"rendered":"https:\/\/www.drfz.de\/?p=24070"},"modified":"2026-08-12T09:08:52","modified_gmt":"2026-08-12T09:08:52","slug":"inflammatory-rheumatic-diseases-in-germany-numbers-adjusted","status":"publish","type":"post","link":"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/","title":{"rendered":"Inflammatory Rheumatic Diseases in Germany: Numbers adjusted"},"content":{"rendered":"\n

1.8 million people affected<\/strong><\/h2>\n\n\n\n

The number of people with inflammatory rheumatic diseases in Germany remains high at 2.6 percent, or 1.8 million people. The main improvement in the latest analysis by the German Rheumatology Research Center (DRFZ), a Leibniz Institute, however, is the better classification of the available data: Dr. Katinka Albrecht and Dr. Johanna Callhoff have compared German studies with European data and also evaluated the respective study methodologies.  For healthcare services, this means that the numbers provide a more reliable basis for needs assessment in rheumatology\u2014a model that other European countries can also use.<\/strong><\/p>\n\n\n\n

The team was thereby able to refine existing estimates for 11 rheumatic diseases, with rheumatoid arthritis being the most common, affecting approximately 1% of the adult population. The new methodology also enables better comparability of the data. This is important because some German studies derive diagnoses solely from accounting data and may therefore overestimate the prevalence of individual diseases.
The study was published in July 2026 in EULAR Rheumatology Open.<\/p>\n\n\n\n

\n
\n

Original publication<\/h2>\n \n \n
\n \n
\n
\n \n The epidemiology of inflammatory rheumatic diseases in Germany in a European context: a systematic review to support workforce planning<\/a>\n\n \n \n <\/span>\n <\/a>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/section>\n\n\n\n\n
\n
\n \n
\n \n\n
\n \"\" <\/div>\n
\n

Dr. Johanna Callhoff<\/h2>\n
\n

Group leader<\/p>\n

\n Group leader: Health Services Research <\/p>\n <\/div>\n <\/div>\n\n

\n

johanna.callhoff@drfz.de<\/a><\/p>\n <\/div>\n Dr. Johanna Callhoff<\/span><\/a>\n<\/article>\n\n

\n \"\" <\/div>\n
\n

Prof. Dr. med. Anja Strangfeld<\/h2>\n
\n

Head of progamme area Epidemiology<\/p>\n

\n Leader: Programme Area 2, PA 2 \u2013 Epidemiology and Health Services Research <\/p>\n

\n Group leader: Pharmacoepidemiology <\/p>\n <\/div>\n <\/div>\n\n

\n

strangfeld@drfz.de<\/a><\/p>\n <\/div>\n Prof. Dr. med. Anja Strangfeld<\/span><\/a>\n<\/article>\n\n

\n \"Dr. <\/div>\n
\n

Dr. med. Katinka Albrecht<\/h2>\n
\n

Scientist<\/p>\n

\n Health Services Research <\/p>\n <\/div>\n <\/div>\n\n

\n

albrecht@drfz.de<\/a><\/p>\n <\/div>\n Dr. med. Katinka Albrecht<\/span><\/a>\n<\/article>\n\n

\n \"\" <\/div>\n
\n

Carlo Veltri<\/h2>\n
\n

\n Versorgungsforschung <\/p>\n <\/div>\n <\/div>\n\n

\n

carlo.veltri@drfz.de<\/a><\/p>\n <\/div>\n Carlo Veltri<\/span><\/a>\n<\/article> <\/div>\n <\/div>\n <\/section>\n","protected":false},"excerpt":{"rendered":"

1.8 million people affected The number of people with inflammatory rheumatic diseases in Germany remains high at 2.6 percent, or 1.8 million people. The main\u2026<\/p>\n","protected":false},"author":4,"featured_media":24095,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[288,291],"tags":[460,389,493],"programme-area-tax":[180],"working-group-tax":[259],"class_list":["post-24070","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-for-patients","category-publications","tag-callhoff","tag-health-services-research","tag-program-area-2","programme-area-tax-programme-area-2","working-group-tax-health-services-research"],"acf":[],"yoast_head":"\nInflammatory Rheumatic Diseases in Germany: Numbers adjusted - DRFZ<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inflammatory Rheumatic Diseases in Germany: Numbers adjusted - DRFZ\" \/>\n<meta property=\"og:description\" content=\"1.8 million people affected The number of people with inflammatory rheumatic diseases in Germany remains high at 2.6 percent, or 1.8 million people. The main\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/\" \/>\n<meta property=\"og:site_name\" content=\"DRFZ\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/drfz.de\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-10T08:13:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-12T09:08:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/08\/26_07_Publication_Katinka_Albrecht_Beitragsbild-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ute Hoffmann\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DRFZ_Berlin\" \/>\n<meta name=\"twitter:site\" content=\"@DRFZ_Berlin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ute Hoffmann\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\\\/\"},\"author\":{\"name\":\"Ute Hoffmann\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/person\\\/a86dc60d63c6fa52cb3ee62f12c72737\"},\"headline\":\"Inflammatory Rheumatic Diseases in Germany: Numbers adjusted\",\"datePublished\":\"2026-08-10T08:13:20+00:00\",\"dateModified\":\"2026-08-12T09:08:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\\\/\"},\"wordCount\":169,\"publisher\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/26_07_Publication_Katinka_Albrecht_Beitragsbild-1.jpg\",\"keywords\":[\"Callhoff\",\"Health Services Research\",\"Program area 2\"],\"articleSection\":[\"For patients\",\"Publications\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\\\/\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\\\/\",\"name\":\"Inflammatory Rheumatic Diseases in Germany: Numbers adjusted - DRFZ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/26_07_Publication_Katinka_Albrecht_Beitragsbild-1.jpg\",\"datePublished\":\"2026-08-10T08:13:20+00:00\",\"dateModified\":\"2026-08-12T09:08:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/26_07_Publication_Katinka_Albrecht_Beitragsbild-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/26_07_Publication_Katinka_Albrecht_Beitragsbild-1.jpg\",\"width\":1280,\"height\":720,\"caption\":\"Grafik zur Pulikation\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/neuigkeiten\\\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Inflammatory Rheumatic Diseases in Germany: Numbers adjusted\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/\",\"name\":\"DRFZ\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#organization\",\"name\":\"Deutsches Rheuma-Forschungszentrum\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/drfz-footer-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.drfz.de\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/drfz-footer-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Deutsches Rheuma-Forschungszentrum\"},\"image\":{\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/drfz.de\\\/\",\"https:\\\/\\\/x.com\\\/DRFZ_Berlin\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/deutsches-rheuma-forschungszentrum-berlin\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCf8nDuqpkWwcmCWmfSTkE3w\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.drfz.de\\\/en\\\/#\\\/schema\\\/person\\\/a86dc60d63c6fa52cb3ee62f12c72737\",\"name\":\"Ute Hoffmann\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g\",\"caption\":\"Ute Hoffmann\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inflammatory Rheumatic Diseases in Germany: Numbers adjusted - DRFZ","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/","og_locale":"en_US","og_type":"article","og_title":"Inflammatory Rheumatic Diseases in Germany: Numbers adjusted - DRFZ","og_description":"1.8 million people affected The number of people with inflammatory rheumatic diseases in Germany remains high at 2.6 percent, or 1.8 million people. The main\u2026","og_url":"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/","og_site_name":"DRFZ","article_publisher":"https:\/\/www.facebook.com\/drfz.de\/","article_published_time":"2026-08-10T08:13:20+00:00","article_modified_time":"2026-08-12T09:08:52+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/08\/26_07_Publication_Katinka_Albrecht_Beitragsbild-1.jpg","type":"image\/jpeg"}],"author":"Ute Hoffmann","twitter_card":"summary_large_image","twitter_creator":"@DRFZ_Berlin","twitter_site":"@DRFZ_Berlin","twitter_misc":{"Written by":"Ute Hoffmann","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/#article","isPartOf":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/"},"author":{"name":"Ute Hoffmann","@id":"https:\/\/www.drfz.de\/en\/#\/schema\/person\/a86dc60d63c6fa52cb3ee62f12c72737"},"headline":"Inflammatory Rheumatic Diseases in Germany: Numbers adjusted","datePublished":"2026-08-10T08:13:20+00:00","dateModified":"2026-08-12T09:08:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/"},"wordCount":169,"publisher":{"@id":"https:\/\/www.drfz.de\/en\/#organization"},"image":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/#primaryimage"},"thumbnailUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/08\/26_07_Publication_Katinka_Albrecht_Beitragsbild-1.jpg","keywords":["Callhoff","Health Services Research","Program area 2"],"articleSection":["For patients","Publications"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/","url":"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/","name":"Inflammatory Rheumatic Diseases in Germany: Numbers adjusted - DRFZ","isPartOf":{"@id":"https:\/\/www.drfz.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/#primaryimage"},"image":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/#primaryimage"},"thumbnailUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/08\/26_07_Publication_Katinka_Albrecht_Beitragsbild-1.jpg","datePublished":"2026-08-10T08:13:20+00:00","dateModified":"2026-08-12T09:08:52+00:00","breadcrumb":{"@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/#primaryimage","url":"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/08\/26_07_Publication_Katinka_Albrecht_Beitragsbild-1.jpg","contentUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2026\/08\/26_07_Publication_Katinka_Albrecht_Beitragsbild-1.jpg","width":1280,"height":720,"caption":"Grafik zur Pulikation"},{"@type":"BreadcrumbList","@id":"https:\/\/www.drfz.de\/en\/neuigkeiten\/inflammatory-rheumatic-diseases-in-germany-numbers-adjusted\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.drfz.de\/en\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.drfz.de\/en\/news\/"},{"@type":"ListItem","position":3,"name":"Inflammatory Rheumatic Diseases in Germany: Numbers adjusted"}]},{"@type":"WebSite","@id":"https:\/\/www.drfz.de\/en\/#website","url":"https:\/\/www.drfz.de\/en\/","name":"DRFZ","description":"","publisher":{"@id":"https:\/\/www.drfz.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.drfz.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.drfz.de\/en\/#organization","name":"Deutsches Rheuma-Forschungszentrum","url":"https:\/\/www.drfz.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.drfz.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/10\/drfz-footer-logo.svg","contentUrl":"https:\/\/www.drfz.de\/wp-content\/uploads\/2024\/10\/drfz-footer-logo.svg","width":1,"height":1,"caption":"Deutsches Rheuma-Forschungszentrum"},"image":{"@id":"https:\/\/www.drfz.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/drfz.de\/","https:\/\/x.com\/DRFZ_Berlin","https:\/\/www.linkedin.com\/company\/deutsches-rheuma-forschungszentrum-berlin","https:\/\/www.youtube.com\/channel\/UCf8nDuqpkWwcmCWmfSTkE3w"]},{"@type":"Person","@id":"https:\/\/www.drfz.de\/en\/#\/schema\/person\/a86dc60d63c6fa52cb3ee62f12c72737","name":"Ute Hoffmann","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/08c654ead40d6cafc50e4ed4fbf2fe4a8a979f96141a813138eec621e1d2879f?s=96&d=mm&r=g","caption":"Ute Hoffmann"}}]}},"_links":{"self":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts\/24070","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/comments?post=24070"}],"version-history":[{"count":2,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts\/24070\/revisions"}],"predecessor-version":[{"id":24085,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/posts\/24070\/revisions\/24085"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/media\/24095"}],"wp:attachment":[{"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/media?parent=24070"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/categories?post=24070"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/tags?post=24070"},{"taxonomy":"programme-area-tax","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/programme-area-tax?post=24070"},{"taxonomy":"working-group-tax","embeddable":true,"href":"https:\/\/www.drfz.de\/en\/wp-json\/wp\/v2\/working-group-tax?post=24070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}